⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LXEO News
Lexeo Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
LXEO
VRTX
ALNY
MRK
TSHA
Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
globenewswire.com
LXEO
Form 8-K
sec.gov
LXEO
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
globenewswire.com
LXEO
Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference
globenewswire.com
LXEO
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February
globenewswire.com
LXEO
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics
globenewswire.com
LXEO
Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy
globenewswire.com
LXEO
Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy
globenewswire.com
LXEO
Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
LXEO